Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01280500 · ClinicalTrials.gov registry record · NA
Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN
A NA study of Asthma, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,040
- Enrollment target
- 2
- Study locations
NCT01280500 is a NA study of Asthma that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,040 participants, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (33% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01280500, a NA study of Asthma, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,040 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall goal is to identify best practices for improving health outcomes for patients with asthma using comparative effectiveness research within an Agency for Healthcare Research and Quality (AHRQ) Practice-Based Research Network (PBRN). This goal will be achieved by completing the following aims: (1) Create a centralized database for comparative effectiveness research on asthma by combining clinical and billing data from one of the largest healthcare systems in the country (Carolinas Healthcare System) with data from the school system, Medicaid, and patient and community-level datasets; (2) Deploy a fully developed integrated approach to asthma management based on the Chronic Care Model; (3) Develop and implement a "shared decision making" approach for asthmatic patients from disadvantaged backgrounds; (4) Implement an electronic data collection system for an existing CDC funded school-based asthma intervention that will allow program evaluation and link school nurses with providers; (5) Evaluate and compare the effectiveness of these three asthma management strategies on: overall healthcare consumption and medical costs; quality of life, school absenteeism and performance; asthma clinical measures; and medication utilization; and (6) Disseminate findings across the state via the statewide PBRN and other network partners. This project has the potential to impact over 30,000 asthma patients across the Carolinas including many patients from disadvantaged backgrounds.
Conditions Studied
Interventions
- OTHER usual care
- BEHAVIORAL electronic medical record
- OTHER Integrated Approach to Care
- OTHER Shared Decision Making
- OTHER school based care
Study Locations (2)
North Carolina
- CMC Elizabeth Family Medicine - Charlotte
- Department of Family Medicine - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,040 participants |
| Start Date | 2011-03 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01280500
The ClinicalTrials.gov registry entry for NCT01280500 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,040 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (33% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 5 interventions - of which usual care is the first listed.
NCT01280500 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01280500 about?
NCT01280500 is a clinical study titled "Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN". The overall goal is to identify best practices for improving health outcomes for patients with asthma using comparative effectiveness research within an Agency for Healthcare Research and Quality (AHRQ) Practice-Based Research Network (PBRN). This goal will be achieved by completing the following ai...
What is the current status of trial NCT01280500?
This trial is currently completed. It is a NA study. The enrollment target is 1,040 participants. The study started on 2011-03. Estimated completion is 2017-08.
What conditions does trial NCT01280500 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT01280500?
The interventions under investigation include: usual care (OTHER), electronic medical record (BEHAVIORAL), Integrated Approach to Care (OTHER), Shared Decision Making (OTHER), school based care (OTHER).
Who is sponsoring clinical trial NCT01280500?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01280500 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.